Table 3: Distribution of cases according to staining intensity of Survivin.
|
Survivin |
Benign prostatic hyperplasia (%) |
Adenocarcinoma prostate (%) |
|
Negative |
3 (20.0) |
0 (0.0) |
|
Positive |
2 (13.3) |
8 (53.3) |
|
Weak positive |
10 (66.7) |
0 (0.0) |
|
Strong positive |
0 (0.0) |
7 (46.7) |
|
Total |
15 (100.0) |
15 (100.0) |